| Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial IS Mackenzie, I Ford, G Nuki, J Hallas, CJ Hawkey, J Webster, SH Ralston, ... The Lancet 396 (10264), 1745-1757, 2020 | 281 | 2020 |
| Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label … IS Mackenzie, A Rogers, NR Poulter, B Williams, MJ Brown, DJ Webb, ... The Lancet 400 (10361), 1417-1425, 2022 | 123 | 2022 |
| Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial IS Mackenzie, CJ Hawkey, I Ford, N Greenlaw, F Pigazzani, A Rogers, ... The Lancet 400 (10359), 1195-1205, 2022 | 85 | 2022 |
| Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning … DA Rorie, A Rogers, IS Mackenzie, I Ford, DJ Webb, B Willams, M Brown, ... BMJ open 6 (2), e010313, 2016 | 78 | 2016 |
| The accuracy of symptoms, signs and diagnostic tests in the diagnosis of left ventricular dysfunction in primary care: a diagnostic accuracy systematic review V Madhok, G Falk, A Rogers, AD Struthers, FM Sullivan, T Fahey BMC family practice 9, 1-8, 2008 | 50 | 2008 |
| Electronic case report forms and electronic data capture within clinical trials and pharmacoepidemiology DA Rorie, RWV Flynn, K Grieve, A Doney, I Mackenzie, TM MacDonald, ... British journal of clinical pharmacology 83 (9), 1880-1895, 2017 | 44 | 2017 |
| Sex, gender, and medical data S Bewley, M McCartney, C Meads, A Rogers bmj 372, 2021 | 38 | 2021 |
| Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders J Coyle, A Rogers, R Copland, G De Paoli, TM MacDonald, IS Mackenzie, ... British journal of clinical pharmacology 88 (3), 1031-1042, 2022 | 32 | 2022 |
| A systematic review of methods used to conduct decentralised clinical trials A Rogers, G De Paoli, S Subbarayan, R Copland, K Harwood, J Coyle, ... British journal of clinical pharmacology 88 (6), 2843-2862, 2022 | 30 | 2022 |
| Toward precision medicine: circadian rhythm of blood pressure and chronotherapy for hypertension-2021 NHLBI workshop report ML Gumz, D Shimbo, M Abdalla, RC Balijepalli, C Benedict, Y Chen, ... Hypertension 80 (3), 503-522, 2023 | 28 | 2023 |
| The Treatment In Morning versus Evening (TIME) study: analysis of recruitment, follow-up and retention rates post-recruitment DA Rorie, RWV Flynn, IS Mackenzie, TM MacDonald, A Rogers Trials 18, 1-8, 2017 | 19 | 2017 |
| Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study A Rogers, E Rooke, S Morant, G Guthrie, A Doney, A Duncan, ... BMJ open 12 (6), e060583, 2022 | 12 | 2022 |
| Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study T Anbarasan, A Rogers, DA Rorie, JW Kerr Grieve, TM MacDonald, ... Journal of human hypertension 36 (1), 32-39, 2022 | 8 | 2022 |
| A novel drug management system in the Febuxostat versus Allopurinol Streamlined Trial: A description of a pharmacy system designed to supply medications directly to patients … A Rogers, RWV Flynn, P McDonnell, IS Mackenzie, TM MacDonald Clinical Trials 13 (6), 665-670, 2016 | 8 | 2016 |
| Factors influencing home blood pressure monitor ownership in a large clinical trial T Anbarasan, A Rogers, DA Rorie, JWK Grieve, RWV Flynn, ... Journal of human hypertension 36 (3), 325-332, 2022 | 7 | 2022 |
| Factors influencing participation and long-term commitment to self-monitoring of blood pressure in a large remote clinical trial: The treatment in morning versus evening (TIME … K Vickneson, A Rogers, T Anbarasan, DA Rorie, TM MacDonald, ... Journal of Human Hypertension 36 (12), 1099-1105, 2022 | 6 | 2022 |
| When innovation outpaces regulations: The legal challenges for direct‐to‐patient supply of investigational medicinal products M Malone, P Ferguson, A Rogers, IS Mackenzie, DA Rorie, ... British Journal of Clinical Pharmacology 88 (3), 1115-1142, 2022 | 6 | 2022 |
| Protocol for assessment of sleep quality and duration in the Treatment In Morning versus Evening (TIME) study: a randomised controlled trial using online patient-reported … A Rogers, I Morrison, DA Rorie, IS Mackenzie, TM MacDonald BMJ open 8 (6), e021890, 2018 | 6 | 2018 |
| A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs) J Coyle, A Rogers, R Copland, G De Paoli, TM MacDonald, IS Mackenzie, ... Trials 23 (1), 614, 2022 | 5 | 2022 |
| Treatment in the Morning versus Evening (TIME) study: feasibility of an online study DA Rorie, A Rogers, IS Mackenzie, E Findlay, TM MacDonald, I Ford, ... Journal of Clinical Trials 6 (5), 1-7, 2016 | 5 | 2016 |
